Therapeutic Landscape of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Human epidermal growth factor receptor 2–positive breast cancer (HER2+BC) is a common malignancy that is prone to recurrence and metastasis in the early stages, resulting in a poor prognosis for patients. Many studies have suggested that targeted therapy promotes clinical outcomes in HER2+BC. With t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jindong, Zou, Yutian, Gao, Ting, Xie, Liming, Tan, Duxun, Xie, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067050/
https://www.ncbi.nlm.nih.gov/pubmed/35499382
http://dx.doi.org/10.1177/10732748221099230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067050/
https://www.ncbi.nlm.nih.gov/pubmed/35499382
http://dx.doi.org/10.1177/10732748221099230

Ejemplares similares